Related references
Note: Only part of the references are listed.Erratum for Zhang et al., Clinical and Molecular Characterizations of Carbapenem-Resistant Klebsiella pneumoniae Causing Bloodstream Infection in a Chinese Hospital (vol 10, e01690-22, 2022)
Na Zhang et al.
MICROBIOLOGY SPECTRUM (2022)
Risk Factors for Mortality and Outcomes in Hematological Malignancy Patients with Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections
Haiyang Meng et al.
INFECTION AND DRUG RESISTANCE (2022)
Ceftazidime/Avibactam-Based Versus Polymyxin B-Based Therapeutic Regimens for the Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infection in Critically Ill Patients: A Retrospective Cohort Study
Guanhao Zheng et al.
INFECTIOUS DISEASES AND THERAPY (2022)
Carbapenem-resistant Enterobacteriaceae bloodstream infections: A case-control study from a pediatric referral hospital in Argentina
Silvina Ruvinsky et al.
FRONTIERS IN PUBLIC HEALTH (2022)
Erratum for Zhang et al., Clinical and Molecular Characterizations of Carbapenem-Resistant Klebsiella pneumoniae Causing Bloodstream Infection in a Chinese Hospital
Na Zhang et al.
MICROBIOLOGY SPECTRUM (2022)
Pharmacoepidemiology of Ceftazidime-Avibactam Use: A Retrospective Cohort Analysis of 210 US Hospitals
Jeffrey R. Strich et al.
CLINICAL INFECTIOUS DISEASES (2021)
Predictors of mortality and clinical characteristics among carbapenem-resistant or carbapenemase-producing Enterobacteriaceae bloodstream infections in Spanish children
M. F. Ara-Montojo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2021)
Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals
Sameer S. Kadri et al.
LANCET INFECTIOUS DISEASES (2021)
Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae Infections: A Retrospective Observational Multicenter Study
Mario Tumbarello et al.
CLINICAL INFECTIOUS DISEASES (2021)
Efficacy of Ceftazidime-Avibactam Versus Polymyxin B and Risk Factors Affecting Clinical Outcomes in Patients With Carbapenem-Resistant Klebsiella pneumoniae Infections a Retrospective Study
Jie Fang et al.
FRONTIERS IN PHARMACOLOGY (2021)
Molecular mechanisms in septic shock (Review)
Gabriel Gorecki et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2021)
Risk Factors of 30-Day All-Cause Mortality in Patients with Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infection
Keh-Sen Liu et al.
JOURNAL OF PERSONALIZED MEDICINE (2021)
Predictors of mortality in patients with carbapenem-resistant Klebsiella pneumoniae infection: a meta-analysis and a systematic review
Yiyi Qian et al.
ANNALS OF PALLIATIVE MEDICINE (2021)
In vitro evaluation of antibiotic synergy for carbapenem-resistan Klebsiella pneumoniae clinical isolates
Anku Goel et al.
INDIAN JOURNAL OF MEDICAL RESEARCH (2021)
Five-year change of prevalence and risk factors for infection and mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection in a tertiary hospital in North China
Yuanyuan Li et al.
ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL (2020)
Clinical Observation and Prognostic Analysis of Patients With Klebsiella pneumoniae Bloodstream Infection
Shuguang Zhang et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)
Treatment of Carbapenem-Resistant Enterobacteriaceae Infections in Children
Kathleen Chiotos et al.
JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY (2020)
Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae
Marco Falcone et al.
CRITICAL CARE (2020)
Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused by Klebsiella pneumoniae Carbapenemase-producing K-pneumoniae
Mario Tumbarello et al.
CLINICAL INFECTIOUS DISEASES (2019)
Early use of polymyxin B reduces the mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection
Qiqiang Liang et al.
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES (2019)
Real-World Experience With Ceftazidime-Avibactam for Multidrug-Resistant Gram-Negative Bacterial Infections
Sarah C. J. Jorgensen et al.
OPEN FORUM INFECTIOUS DISEASES (2019)
Synergetic Effects of Combined Treatment of Colistin With Meropenem or Amikacin on Carbapenem-Resistant Klebsiella pneumoniae in vitro
Lan Yu et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2019)
Risk factors for carbapenem-resistant K. pneumoniae bloodstream infection and predictors of mortality in Chinese paediatric patients
Ye Zhang et al.
BMC INFECTIOUS DISEASES (2018)
Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections in a Chinese Children's Hospital: Predominance of New Delhi Metallo--Lactamase-1
Fang Dong et al.
MICROBIAL DRUG RESISTANCE (2018)
Stereotypic Immune System Development in Newborn Children
Axel Olin et al.
CELL (2018)
Increased 30-Day Mortality Associated With Carbapenem-Resistant Enterobacteriaceae in Children
Kathleen Chiotos et al.
OPEN FORUM INFECTIOUS DISEASES (2018)
Comparing the Outcomes of Patients With Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Bacteremia
Pranita D. Tamma et al.
CLINICAL INFECTIOUS DISEASES (2017)
Use of tigecycline in pediatric clinical practice
Maria Vincenza Mastrolia et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2017)
Monocyte Subsets Are Differentially Lost from the Circulation during Acute Inflammation Induced by Human Experimental Endotoxemia
Tamar Tak et al.
JOURNAL OF INNATE IMMUNITY (2017)
Clinical and Bacterial Risk Factors for Mortality in Children With Carbapenem-resistant Enterobacteriaceae Bloodstream Infections in India
Laura E. B. Nabarro et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2017)
Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae
Liangfei Xu et al.
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS (2017)
Carbapenem-resistant Klebsiella pneumoniae in high-risk haematological patients: factors favouring spread, risk factors and outcome of carbapenem-resistant Klebsiella pneumoniae bacteremias
Alessandra Micozzi et al.
BMC INFECTIOUS DISEASES (2017)
Carbapenem-Resistant Enterobacteriaceae Infections in Children
Kathleen Chiotos et al.
CURRENT INFECTIOUS DISEASE REPORTS (2016)
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey
Enrico Maria Trecarichi et al.
AMERICAN JOURNAL OF HEMATOLOGY (2016)
Combination Regimens for Treatment of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections
A. Gomez-Simmonds et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Clinical Characteristics of Carbapenem-resistant Klebsiella pneumoniae Infections in Ill and Colonized Children in Colombia
Alejandro Diaz et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2016)
Monocyte-mediated defense against bacteria, fungi, and parasites
Gregoire Lauvau et al.
SEMINARS IN IMMUNOLOGY (2015)
Treatment Options for Carbapenem-Resistant Enterobacteriaceae Infections
Haley J. Morrill et al.
OPEN FORUM INFECTIOUS DISEASES (2015)
Carbapenem-Resistant Enterobacteriaceae in Children, United States, 1999-2012
Latania K. Logan et al.
EMERGING INFECTIOUS DISEASES (2015)
Neonatal Immune Adaptation of the Gut and Its Role during Infections
Emilie Tourneur et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2013)
Predictive scoring model of mortality in Gram-negative bloodstream infection
M. N. Al-Hasan et al.
CLINICAL MICROBIOLOGY AND INFECTION (2013)
Predictors of mortality in multidrug-resistant Klebsiella pneumoniae bloodstream infections
Pierluigi Viale et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2013)
Infections Caused by Carbapenem-resistant Gram-negative Pathogens in Hospitalized Children
Helena C. Maltezou et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2013)
Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy
Mario Tumbarello et al.
CLINICAL INFECTIOUS DISEASES (2012)
Excess Deaths Associated With Tigecycline After Approval Based on Noninferiority Trials
Paritosh Prasad et al.
CLINICAL INFECTIOUS DISEASES (2012)
Carbapenemases in Klebsiella pneumoniae and Other Enterobacteriaceae: an Evolving Crisis of Global Dimensions
L. S. Tzouvelekis et al.
CLINICAL MICROBIOLOGY REVIEWS (2012)
Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems?
G. L. Daikos et al.
CLINICAL MICROBIOLOGY AND INFECTION (2011)
Defective innate immunity predisposes murine neonates to poor sepsis outcome but is reversed by TLR agonists
James L. Wynn et al.
BLOOD (2008)
Neonatal survival 1 - 4 million neonatal deaths: When? where? why?
JE Lawn et al.
LANCET (2005)
Neutrophil CD11b expression and circulating interleukin-8 as diagnostic markers for early-onset neonatal sepsis
I Nupponen et al.
PEDIATRICS (2001)